Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Healthcare providers may need to assess kidney function, review concurrent medications, evaluate glycemic control in patients with diabetes, or adjust the GLP-1 medication dose or schedule
Limitations of current evidence include small sample sizes, short study durations, heterogeneous patient populations, and varying dosing regimens
In humans, limited evidence suggests that berberine may lower cholesterol, triglycerides, and blood sugar levels
B., Cooper, D
Key Takeaway: While both medications target the GLP-1 pathway to reduce hunger, tirzepatide adds a second pathway (GIP) to further support metabolic health
US$ 25.24
US$ 28.34
US$ 23.92
